`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`INNOPHARMA LICENSING, INC., INNOPHARMA LICENSING LLC,
`INNOPHARMA INC., INNOPHARMA LLC,
`MYLAN PHARMACEUTICALS INC., and MYLAN INC.
`Petitioner,
`
`v .
`
`SENJU PHARMACEUTICAL CO., LTD., BAUSCH & LOMB, INC., and
`BAUSCH & LOMB PHARMA HOLDINGS CORP.
`Patent Owner.
`__________________
`
`IPR2015-00902 (Patent 8,669,290 B2)
`IPR2015-00903 (Patent 8,129,431 B2)1
`__________________
`
`BEFORE FRANCISCO C. PRATS, ERICA A. FRANKLIN, and GRACE
`KARAFFA OBERMANN, Administrative Patent Judges
`
`ADR STATEMENT
`
`1 The word-for-word identical paper is filed in each proceeding identified in the
`
`heading.
`
`
`
`IPR2015-00902 (Patent 8,669,290)
`IPR2015-00903 (Patent 8,129,431)
`
`Petitioner and Patent Owner
`
`(collectively “Parties”) have conferred
`
`regarding alternative dispute resolution and have discussed potential settlement.
`
`As of this time, the Parties have not reached any agreement to resolve their
`
`disputes. This paper is being filed by counsel for Petitioner with the approval of
`
`Patent Owner.
`
`RESPECTFULLY SUBMITTED,
`
`ALSTON & BIRD LLP
`
`Date: October 7, 2015
`
`/s/ Jitendra Malik
`
`Jitendra Malik (Reg. No. 55823)
`4721Emperor Boulevard, Suite 400
`Durham, North Carolina 27703
`Telephone: 919-862-2200
`Fax: 919-862-2260
`Jitty.Malik@alston.com
`
`Lead Counsel for Petitioners
`InnoPharma Licensing Inc., InnoPharma
`Licensing LLC, InnoPharma Inc.,
`InnoPharma LLC, Mylan
`Pharmaceuticals Inc., and Mylan Inc.
`
`1
`
`
`
`IPR2015-00902 (Patent 8,669,290)
`IPR2015-00903 (Patent 8,129,431)
`
`CERTIFICATION OF SERVICE
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned certifies that on the 7th day
`
`of October 2015, a complete copy of the foregoing ADR Statement was served
`
`via email on counsel of record for the Patent Owner:
`
`Bryan C. Diner
`bryan.diner@finnegan.com
`
`M. Andrew Holtman
`andy.holtman@finnegan.com
`
`Justin J. Hasford
`justin.hasford@finnegan.com
`
`Joshua L. Goldberg
`joshua.goldberg@finnegan.com
`
`Respectfully submitted,
`
`Alston & Bird LLP
`
`By: /s/ Jitendra Malik
`
`Jitendra Malik, Ph.D.
`Reg. No. 55823
`Alston & Bird LLP
`4721 Emperor Blvd., Suite 400
`Durham, NC 27703-8580
`jitty.malik@alston.com
`
`Bryan Skelton, Ph.D.
`Reg. No. 50893
`Alston & Bird LLP
`
`2
`
`
`
`IPR2015-00902 (Patent 8,669,290)
`IPR2015-00903 (Patent 8,129,431)
`4721 Emperor Blvd., Suite 400
`Durham, NC 27703-8580
`bryan.skelton@alston.com
`
`Lance Soderstrom
`Reg. No. 65405
`Alston & Bird LLP
`90 Park Avenue
`15th Floor
`New York, NY 10016-1387
`lance.soderstrom@alston.com
`
`Attorneys for Petitioners
`InnoPharma Licensing, Inc.,
`InnoPharma Licensing LLC,
`InnoPharma Inc., InnoPharma
`LLC, Mylan Pharmaceuticals
`Inc., and Mylan Inc.
`
`3